中国创新药出海交易“新玩法”

橙色：该企业与中国企业达成3笔及以上重磅交易蓝色：该企业与中国企业无重磅交易MNC优势领域MNC重点关注领域该MNC有重磅交易/并购MNC传统优势领域MNC重点关注领域橙色：该企业布局新兴疗法种类较多100%100%100%••••22%73%16%8%7%14%15%8%13%12%11%9%47%48%29%25%23%16%15%13%67%18%5%8%7%3%5%5%8%4%4%18%9%6%7%5%28%18%4%4%21%15%4%5%8%16%12%35%14%13%14%15%25%5%17%14%3%5%28%10%6%18%20%911192568697810812619116112020225251201,7642,6024502209075,3504,88010,98422,85610337227155718522462011,6852,0108,985110111117152018292533100.00120.00146.0095.0092.0052.0025.0039.0035.0020.0092.0031.0030.5022.0013.0011.5017.0016.0010.0011.532.064.70192.00179.53176.50137.7050.0631.50Cidara Therapeutics；Neuraminidase抑制剂Vigil Neuroscience ；TERM2抑制剂IDRx；c-Kit抑制剂交易时间被收购方收购方总金额(亿美元)关联项目了 解 更 多了 解 更 多